
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 18 November 2024
Sec. Ethnopharmacology
Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1516840
This article is a correction to:
Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in mice
A Corrigendum on
Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in mice
by Wu Q, Zhu F, Yao Y, Chen L, Ding Y, Su Y and Ge C (2024). Front. Pharmacol. 15:1408459. doi: 10.3389/fphar.2024.1408459
In the published article, there was an error regarding the Affiliation for Chaoliang Ge. As well as having affiliation 3, they should also have ‘School of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, China.’
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Si-Ni-San, intestinal flora, short-chain fatty acids, hepatocyte apoptosis, liver fibrosis, pseudo germ-free mice
Citation: Wu Q, Zhu F, Yao Y, Chen L, Ding Y, Su Y and Ge C (2024) Corrigendum: Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in mice. Front. Pharmacol. 15:1516840. doi: 10.3389/fphar.2024.1516840
Received: 25 October 2024; Accepted: 28 October 2024;
Published: 18 November 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Wu, Zhu, Yao, Chen, Ding, Su and Ge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chaoliang Ge, Z2VjaGFvbGlhbmdAMTI2LmNvbQ==; Yong Su, c3V5b25nQGFobXUuZWR1LmNu
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.